A groundbreaking AI-designed vaccine for Crimean-Congo haemorrhagic fever has entered human trials, marking a world-first for medical research. Developed by Oxford University and Basecamp Research, this initiative showcases AI’s potential to drastically accelerate vaccine development for emerging infectious diseases. The trial aims to assess safety and immune response, potentially ushering in a new era of AI-assisted medicine.
Trending
- 7.6L volunteers within hours: Annamalai’s ‘political movement’ becomes an instant hit
- Henry Nowak case: How handcuffed UK student’s murder by Sikh man sparked national outrage – timeline of events
- BCCI confirms timings of India squad announcement for UK tour
- ‘People’s anger forced Cong to change CM in Karnataka’: PM Modi
- ‘Success of reforms and hard work Indians’: PM Modi hails 7.7% GDP growth in FY26
- ‘Are you from India?’ Donald Trump takes swipe at reporter in Oval office, triggers racism row
- Watch: Trump takes swipe at Indian journalist, sparks racism row
- CBSE denies ‘data breach’ despite repeated cyber attacks for past 3 days; files complaint
World’s first AI-designed vaccine developed by UK scientists enters human trials
By
Add A Comment